News

Evotec is expected to apply its integrated and innovative drug discovery platform in combination with its disease biology expertise against targets nominated by Genentech. This will include assay

Janssen Pharma had launched Velcade in Japan in 2006, where it is approved for relapsed multiple myeloma. Velcade is currently approved in more than 90 countries and has

Mr Gemignani brings to Coronado 25 years of accounting, planning and finance experience that includes employment at a broad spectrum of life science businesses including emerging biotech, big

Cipher Pharma is currently preparing for the US commercial launch of Cip-Tramadol, which includes securing a marketing partner and finalising commercial manufacturing requirements. Cipher Pharma said that the

Diazyme said that the assay can be run from a simple finger stick blood sample obtained in a physician’s office and delivers accurate and reliable results in minutes.

The prospective, single-arm study is ongoing to evaluate the drug-eluting stent for the treatment of peripheral artery disease (PAD). Results of a separate pivotal randomized study in a

A5 labs is a contract research based organisation servicing the pharmaceutical and biotechnology companies in North America. The company utilises its research capabilities to license and acquire novel

Halozyme has posted a net loss of $11.8m for the first quarter 2010, or $ 0.13 per diluted share, compared to $14.7m, or $ 0.18 per diluted share,

For the first quarter of 2010, Watson Pharmaceuticals posted a net income of $69.8m, or $0.57 per diluted share, compared to $49.1m, or $0.43 per diluted share, for